StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 285.00
-11.00 (-3.72%)
Feb 6, 2026, 3:30 PM JST
StemRIM Market Cap
StemRIM has a market cap or net worth of 17.86 billion as of February 6, 2026. Its market cap has decreased by -6.81% in one year.
Market Cap
17.86B
Enterprise Value
11.48B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
285.00
Market Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 17.86B, a decrease of -64.14%. That is a compound annual growth rate of -14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 18.55B | 12.55% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 26.40B |
| AnGes | 22.56B |
| Japan Tissue Engineering | 21.32B |
| Renascience | 19.57B |
| CanBas | 16.07B |
| ReproCELL | 15.15B |
| Immuno-Biological Laboratories | 14.53B |
| Kubota Pharmaceutical Holdings | 13.50B |